Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 16, 2022
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
[ Tue, Aug 16th 2022
] - WOPRAI
Mon, August 15, 2022
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
Mike Kratky Maintained (VRDN) at Buy with Increased Target to $40 on, Aug 15th, 2022
Mike Kratky of SVB Leerink, Maintained "Viridian Therapeutics, Inc." (VRDN) at Buy with Increased Target from $32 to $40 on, Aug 15th, 2022.
Mike has made no other calls on VRDN in the last 4 months.
There is 1 other peer that has a rating on VRDN. Out of the 1 peers that are also analyzing VRDN, 0 agree with Mike's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mike
- Kalpit Patel of "B. Riley Securities" Initiated at Strong Buy and Held Target at $25 on, Thursday, June 23rd, 2022
